Cas 50700-72-6 Vecuronium Bromide Injection Powder Api Skeletal Muscle Relaxant

Basic Information
Place of Origin: China
Minimum Order Quantity: Negotiation
Price: Negotiation
Packaging Details: Drum/Bag
Delivery Time: Negotiation
Payment Terms: L/C, D/A, D/P, T/T
Supply Ability: Negotiation
Cas No: 50700-72-6 Ec No: 256-723-9
Name: Vecuronium Bromide Synonyms: Norcuron; (+)-1-(3,17-Diacetoxy-2-piperidino-5-androstan-16-yl)-1-methylpiperidinium Bromide
Molecular Formula: C34H57BrN2O4 Molecular Weight: 637.73138
Melting Point: 227-229°C Boiling Point: N/A
Density: N/A Solubility: Slightly Soluble In Water, Freely Soluble In Methylene Chloride,
Risk Code: R36/37/38-22 Safe Description: S26-37/39
High Light:

CAS no 50700-72-6


vecuronium bromide api


50700-72-6 Vecuronium Bromide

VECURONIUM BROMIDE ; CAS 50700-72-6; Skeletal muscle relaxant


Name Vecuronium bromide
Synonyms Norcuron; (+)-1-(3,17-Diacetoxy-2-piperidino-5-androstan-16-yl)-1-methylpiperidinium bromide
Molecular Formula C34H57BrN2O4
Molecular Weight 637.73138
CAS Registry Number 50700-72-6
EINECS Number 256-723-9
Melting point 227-229°C
Boiling point N/A
Solubility Slightly soluble in water, freely soluble in methylene chloride,
Density N/A
Safety Description S26-37/39
Risk Codes R36/37/38-22

Product Description:


This product is a monomeric ammonium steroid medium effect non-depolarizing muscle relaxation drug, similar in structure to pancuronium bromide, by competing with acetylcholine at the nicotinoid receptor in the striated muscle motor endplate to block the conduction between nerve endings and striated muscle. Unlike depolarizing neuromuscular blockers such as succinylcholine, it does not cause bundle fibrillation of muscle fibers.

Product Use:

Medium effect non - depolarization muscle relaxation drug, has a strong muscle relaxation effect. It has short duration, rapid recovery, and does not cause bronchospasm and blood pressure drop, and has little effect on the cardiovascular system. Used for endotracheal intubation and surgery.
Cas 50700-72-6 Vecuronium Bromide Injection Powder Api Skeletal Muscle Relaxant 0Cas 50700-72-6 Vecuronium Bromide Injection Powder Api Skeletal Muscle Relaxant 1
Product Catalogue:

Number Cas Name
4 53-43-0 DHEA
5 50-28-2 Estradiol
6 53-03-2 PREDNISONE
9 5630-53-5 TIBOLONE

About us

Zhejiang chemical import and export co., LTD. (zhejiang), formerly known as zhejiang branch of China national chemical import and export corporation, was established in December 1980. In 1988, he was transferred from Sinochem Corporation to be in charge of Zhejiang Provincial Department of Commerce and was renamed Zhejiang Chemical Import and Export Company. In 2003, the company changed its name to Zhejiang Chemical Import and Export Co., Ltd after the reform of state-owned enterprise shareholding system.

In 2008, it was incorporated into Zhejiang International Trade Group (one of the top 500 enterprises in China) and became the core member of the group's business circulation sector. The registered capital of the company is 72.5 million yuan, of which 38% are owned by the state and 62% are owned by employees.
There are 195 employees in the company, more than 79% of whom have bachelor's degree, 36% of whom are graduate students, and more than 90% of the salesmen have pharmaceutical and chemical background. The company is mainly engaged in the import and export trade of pharmaceutical raw materials and intermediates, dyes, pesticides, basic chemicals, fine chemicals, food and feed additives, pharmaceutical preparations and other products. The company has established close economic and trade relations with more than 100 countries and regions around the world. The company has wholly-owned subsidiaries Ruike International Trade Co., Ltd., Zhejiang Ruikai Chemical Co., Ltd., Zhejiang Fukai Import and Export Co., Ltd., joint-stock enterprise Zhejiang Aotokang Pharmaceutical Group Co., Ltd.
In recent years, especially since the establishment of the new team in 2019, the company has adhered to the development led by the party building, energized by reform, and improved efficiency by management. The company has shown a steady upward momentum of development. In 2020, the company achieved revenue of 3.337 billion yuan, total profit of 56.12 million yuan, total import and export of 450 million dollars.

In 2019, the company was rated as China Council for the Promotion of International Trade (CCPIT) Recommended Certification Enterprise, Top 100 International Pharmaceutical Enterprises -- a high-quality supplier and partner in the international market; In 2020, Zhejiang Provincial Department of Commerce and other units rated as the province's epidemic prevention and medical materials import outstanding contribution enterprise, Zhejiang Provincial Tax Bureau identified as the export tax rebate enterprises.

Contact Details
William Wang

Phone Number : +86-13588430486

WhatsApp : +8613588430486